國立臺灣大學法律學院科際整合法律學研究所 碩士論文
Graduate Institute of Interdisciplinary Legal Studies College of Law
National Taiwan University Master Thesis
緩起訴附命完成二級毒品戒癮治療之地方實作與規劃變遷 歷程考察
Survey on Changing Process of Local Practice and Policy Planning about the Schedule II Drug Rehabilitation Treatment
Program during the Deferred Prosecution
高世軒 Shih-Shiuan Kao
指導教授：李茂生 博士 Advisor: Mau-Sheng Lee, Ph.D.
中華民國 109 年 7 月 July 2020
... i
... ii
... iii
... iv
... v
... viii
... ix
... x
... 1
... 1
... 4
... 10
... 13
... 17
？ ... 18
理 ... 22
... 36
... 46
... 49
... 51
... 57
... 76
... 83
... 87
... 87
... 88
... 91
... 91
... 94
1-1 ... 96
1-2 ... 97
1-3 ... 98
2-1 ... 100
2-2 ... 101
3-1 ... 102
... 102
... 103
... 104
... 104
... 104
... 107
... 107
3-1 S12
... 58 3-2
... 63
圖 3-3 2017
14–15 S12 ... 79
1 ... 14
——
2016
——
——
R05/212
Dana DTL
2020 7 12
2008–2018
2018
By textual analysis on archives and other materials, and interviews with practioners and drug users, I examine the background of insitution development, with the establishment, changing process (2008–2018) and content of local practice, on the schedule II drug rehabilitation treatment program during the deferred prosecution, therefore attempt to demonstrate possible factors affecting the changing of the program. Three arguments can be drawn from the findings. First, there are “remedy” and the “justice” logics in the drug user treatments, and ratio of these two logics can be distributed and adjusted via the “patient- offender” construction as a discursive apparatus; and these two logics work in concert in the
“contingency management”, the core principle of the schedule II drug rehabilitation treatment program. Second, individual actors are largely limited by their relationships with other actors and resources, thus contingently form assemblages of policy and practice, along with other actors; the field of addiction intervention, until 2018, hadn’t been institutionalized and monopolized by any specific actors, therefore different actors could enter this field, selectively introduce different knowledges and construct local treatment programs. Finally, although the governing capacity of the state is limited, by “policy pilot programs” and assemblages by local actors, heterogenous drug rehabilitation treatment programs could be developed across regions; however, this heterogeneity also make the comparison and the direct transplant of other programs into different regions infeasible. My policy suggestion is that, only thorough delicate and qualitative understanding of every site of local practices, the changing process and its conditions of such practices, could policy makers abstract modular policy options; by clearly elucidation of historical conditions and available resources behind these modular options, and make such options as illuminating paradigms (but not as fixed options), all local actors might introduce and adapt these modular policy options into new local practices.
Keywords: addiction treatment, “patient-offender”, logic, assemblage of policy, contingency
2020 2 12
1
— 2 2020 55,126
27,480 8,833 3
2020 32,381
4,801 4 4,680 5
內
6
2016 7
1
2 https://www.rjsd.moj.gov.tw/rjsdweb/book/Book_Detail.aspx?book_id=379 2020 6 22
3 8,163 3,876
3,853 3,413
4 6,974 4,005 3,903
2,759 2,236
5 28,086
6
7 https://www.ey.gov.tw/Page/5A8A0CB5B41DA11E/47bbd6cf-5762-4a63-a308-
內
8
8
— 2003
2003
— 95
145–204 2006
2006 31 6 15–24 2007
10 283–322 2007 2007
2008
11 89–110 2008 2
NSC 96-2412-H-015-001-SS2 2010 —
2010 13 1-65 2011
30 6 604–616 2011
— 29 2
111–180 2011
— 2012
2013 17 2 193–212 2014
2015 1998–
2017 2017
2008 2018
內
——
— 1998
—
—
—
2017
307–345 2018
2003 2017
1998–2017 9
1998–2017
10
2009
2015
11
9 8
10 8 iii
11 —
path
dependency contingency 12
13
產 ⋯⋯
產
the office assemblages Deleuze Guattari
14
產
⋯
12 James Mahoney, Path Dependence in Historical Sociology, 29 THEORY &SOC'Y 507 (2000); James Mahoney
& Kathleen Thelen, A Theory of Gradual Institutional Change, in EXPLAINING INSTITUTIONAL CHANGE: AMBIGUITY,AGENCY, AND POWER 1–38 (2000)
13 8 2011
15
—
16
Annemarie Mol
Mol
說
17
18
15 8 332–333
16 8 26–28
17 Annemarie Mol 2 36–38
2019
18 Mol
Mol Mol 17 42
reasoning ratio
19 Mol
說 說
constructive ambiguity
Peter Conrad
內
20
Conrad Conrad
Conrad
19 8
20 Peter Conrad 7–9 2015
/ /
bestimmt
21
22
1998 1998
1998
21
22
Conrad 1980
PETER CONRAD &JOSEPH W.SCHNEIDER EDS.,DEVIANCE AND MEDICALIZATION: FROM BADNESS TO SICKNESS (expanded ed. 1992)
Peter Conrad xviii lxxi 2015
2005
Conrad
23
⋯
說
24
2015 25
network of expertise
26
產 27
23
24 Conrad 20 5
25 21 15–
76 2015
26 25 20
27 STS
4 65–108
⋯⋯ 28
29 30
2008–18 內
絕
31
28 25 21
29 25 21
30 25 22
31
32
33 34
1
32 1-1 1-2
33
34 email
35
閱 內
35
絕
內
36
2016
吳
2016–2018
內
36
內 說
contingent
說
1
S01 51–60 2017.04
S02 51–60 2017.11
S03 51–60 2017.06
S04 61–70 2017.05/
2018.08
S05 51–60 2018.05
S06 51–60 2018.05
S07 51–60 2018.08
S08 41–50 2018.07
S09 51–60 2018.04
S10 61–70 2018.05
S11 51–60 2017.07
S12 51–60 2018.08
S13 61–70 2018.08
S14 2018.08
31–40 41–50
21–30 2018.06
31–40 2018.06 S14
S14
31–40 2018.07
21–30 2018.07
/
expressive function 37
內 內
內
v.
37 Cass Sunstein 1996 On the Expression Function of Law
expression function of law “the function of law in ‘making statements’ as opposed to controlling behavior directly” 2024 Sunstein
social norm 2025
Cass R. Sunstein, On the Expressive Function of Law, 144 U. PA. L. REV. 2021 (1996). Available at:
？
1997 內
38 說
…
[sic]
…
39
38
8
2001 8
39 83 83 339 1994
87 5 20
40
內
內
說 內
476 544 內 41
40 1 2015
476
544
說
說 說
脫
脫
42
43
42
17–67 2010
2011
43
/
內
說 內
說
內
內
44
8 286–304
/
44
內
deliquency
1955 1992
45
理
83 96 3582 97
397 104 11
105 10
81 1
81 2 1998
2004.04.23 83
45 https://lis.ly.gov.tw/lglawc/lglawkm
S04
46
47
46 S04 1993 8
1993 8 25 07 2017 6 17
47 1992 5 11 16
2017 6 16
48
S04 1993
S04
49
說 50
48 46
49
50 8
2007
——
40
1998
1993
51
1990
52
/
51
1993 5
25 06 2017 6 16
52
1–9 1990
1982 8 2
1989
3 1 Alcohol, Drug Use Disorder
Tsukasa Koyoma Itaru Yamashita
1990 4 2
— — bio- psycho-social disorder
DSM-III-R psychoactive
substance use disorder
1981–86
53
54 55
56
57
gateway drug theory 1990
/ 58
1993 5 4–5
53
54 52
55 — —
disorder
56 DSM-III-R 1987
57
58 S04
NIDA
methamphetamine heroin
[sic]
[sic] NIDA
[sic]
59
59 II.
60 61
吿
60 S06 S10
2017 2018 NIDA S10
disease model moral model
socialization model self-medication model
— — NANCY D.
CAMPBELL, DISCOVERING ADDICTION:THE SCIENCE AND POLITICS OF OF SUBSTANCE ABUSE RESEARCH
(1st ed. 2007)
61 — —
1993 5 12 11 2017 6 16
62
1994 12
1997
內 27
9
說 內
內 1997
內
63 1997
62 1993 6 15 06
2017 6 27 2-2
63
Clonidine S04 S10
1998
1999
64
⋯⋯
Clonidine Clonidine
Clonidine
—— 7 1 48–57 1993
64 2244 70–74 (88) 882600617
1999 12 20
— —
65
65 S04
S04
S04 S02
risk factor standardized interview 2005 S02
S02
2003 66 1999
S11
S11
1:2000 1:2000
S11
66 2431 1–14 (92) 0922200545
2003 7 18
67
68
69
說
S11
⋯ ⋯
20 20
1234 5678
1997 內
說
67 S11
68 S11
SOP
69 S11
說 說
S04
70
內
說
S04
71
說
70 S04
71
S11
construct ratio
Foucault
History of the Present David Garland
David Garland, What is a ‘‘History of the Present’’? On Foucault’s Genealogies and their Critical Preconditions,
72
內
73 —
74
72 8
73
83 2009
74 Conrad 20
75
76
—
說 —
2003 injecting durg user IDU
HIV
S01 說
S03
77
75
8 321
76 8 336
77 S04 2003
IDU HIV
S03 2002
2002 2003
2003
S03
S03
S03
78
2003 SARS
IDU HIV 2003 12 31
78 S03
1999 2011
79
HIV 2004 IDU HIV
80
2005
81 2005
82 83
84
79 34
2017
80
64–65 2017
81 80 63–67
82
83 80 67
84
12
73 83–84
152
85
S01 說 IDU
HIV 86 2006 11
87 1/10
88
85
28 2017
86 S01
87 79 33
mL
——
88 24 2017
89
90 nalaxone Suboxone®
產
91
nalaxone
產 92
S04 2002–04
內 IDU HIV
89 80 70
90
91
S09
S09
120 30
93
2006 94
95
96
2010 10
97
S04
98
S04 1980
90 IDU HIV
93 S04 80 70
S04
S04
S04 CDC
94 80 70
95 80 70
96 S01
S01
97
44 2017
98 S04
說
S04
99
360 100
IDU HIV
101
2006 4
102 103
99 79 34–35
100 97 45
101 90
102 73 84
103
104
2007
105 106
107
2002
2007 08
108
104
55 2017
105 104 55–58
106 97 7 259 2008
107
108 106 259–60
109 2007
110
111
說
112 內
說
109 97 11 29 2008
110
2007 12 06 A12
https://www.ly.gov.tw/Pages/Detail.aspx?nodeid=12278&pid=153044 2020 6 13
111 106
266
HIV HIV
HIV
⋯⋯ 說
HIV
——
HIV
HIV
113
說
說
113 1 33 2017
https://web.stanford.edu/~xgzhou/zhou_book2017.pdf 2020 6 23
2016–18
2016–18
/
114
115
116
117
115
116
117 / S04
compliance S02 S12
118
119
120
1994 S04
118
119
121 122
2008 24
S04
123 S04
S04
S13 124 S13
S04
125
S04 內
S13
S04 S13
121 1990 S02 S02
S04 2009
2009
122 S06
123 S04
109
124 S13 S04
S13
125 S04 2011 powerpoint
戶 戶
2009
126
S04 127 128 2013
S04
說 S04
129 說
內
產
130 S04 S13
126 S04 S13
127 S04
128 S07 2011
2012 4 S04
S11
129 S04 powerpoint 2011
S04
S13 2011 S04
131
132
2013
133
134 說 說
說
135
說
說
S07 “turn
down”
136
131 S04 S07
S12
132
S04
2014 2012
https://www.audit.gov.tw/p/405-1000-1589,c192.php?Lang=zh-tw
2020 6 19 S12
2015 7 14 6 7
133 S06
134 S06 S12
135 S07
136 S07 S04 S07
S06 S07
S13
137
S06 S12
138
2014 S12
S12 130
⋯ 偷
S12 139
S12
137 S13
138 S12
139
MDMA
S12
140 141
S12
Narcotics Anonymous NA
S12 NA
NA
S12
S12 S12
2015 NGO
NGO
142 S12 S06 S06
2017
140 141
142 2016 6 20
143
2019
NGO 2020 24
內
2018 3-1
內
內 S12
143 2014 2016
2017
3-1 S12
說
歲
144
歲 歲
內
S13 S13
S13 S13
S13
S12
S12
144 2018.08.21 2018.05.25
2014.06.27 2014.06.15 2009.05.04
2009.04.24 S13
145
S12
說
⋯
⋯
——
S12
145 106
2020 3 23 https://www.cy.gov.tw/CyBsBoxContent.aspx?s=17005 2020 5 17
109 0013 pdf 18 2010
S06
146 S06 S07
絕
S07
2020 24
S12
⋯⋯
147
內
drug courts RANT Risk and Needs Triage
148 3-1 S12
說
說 說⋯⋯
NIDA SBIRT Screening, Brief Intervention, and Referral to Treatment 149
147 148
RANT
3-2
145 50–51 RANT
104
PG10408-0073 104 2016 7
https://www.grb.gov.tw/search/planDetail?id=11589444 2020 6 8
149 SAMHSA, https://www.integration.samhsa.gov/clinical-practice/sbirt (last visted: May 29, 2020)
DAST The Drug Abuse Screening Test 150
151
S12 S13
2018 18 歲
150 SAMHSA https://www.integration.samhsa.gov/clinical-practice/sbirt/DAST.pdf (last vesited: May 29, 2020)
151 108
12.108 ( ).pdf
https://dep.mohw.gov.tw/domhaoh/cp-4097-50020-107.html ( 2020 5 29 ) 3-2
RANT
S07
152
⋯ OK OK
⋯
152
⋯ ⋯
153
154 S12
說
S12
155
內
153
154 S12
145
S12
155 145
2016 6 20
156
X
156
S13 2018
1 6 1
9 12
“active using the durg” S06
157
158 內 說
17
2016 2017 X
2,500 4,776 2016
1,470 2018
4,900
psychotic symptoms
157 S06 S07
158
絕 S04 S07
contingency management
說 159
160
說
161
2018 2017–18
159 S06
160 S07
161 109 2020
drug use disorder
contingency management
https://dep.mohw.gov.tw/domhaoh/cp-
4097-50627-107.html 2020.05.30 pdf 7
162
容
S06 S06
S05
S06
163 S05 S06
S06
S06 內
內
內 S07
162
2018 164
內 2017
2018
165
164 S06
165
166 167 S07 說
⋯ ⋯
OK ⋯
⋯ 106 ⋯
S08 S08 ⋯ ⋯⋯
⋯
S08 ⋯⋯
⋯ ⋯⋯ ⋯
⋯⋯ ⋯
⋯
166 S07
motivational interviewing
DIANE DOYLE PITA, ADDICTIONS COUNSELING: A PRACTICAL AND
COMPREHENSIVE GUIDE FOR COUNSELING PEOPLE WITH ADDICTIONS (revised ed., 2004) S02 S06 S07
S06 S02
167
⋯
S07
⋯
S07
⋯ ⋯
⋯
⋯
⋯ ⋯ ⋯ ⋯
⋯ ⋯
⋯
S07
168
S02 169 1990 S04
S02 170
2006
2006 2007
S02 S04 psycho-social
171
S04
S02 S05
S07
S02
168 S07
169 121
170
171 S02
S04 S04
S04 S12
⋯⋯
S12
172
⋯ ⋯
⋯ ⋯ ⋯⋯
⋯⋯
⋯⋯
⋯⋯
⋯
⋯
⋯
172 151 2007
104 61 2012
MATRIX model
173
S05
174
S04
“structured”
S07 說
S05 solid data
relapse
說 說
173 S07
174 S07 S05 2018
175 176
2016
S12 2017
2017
1,470 1,140
175
176 OK
drug free
177 178
——
3-3
K
內
177 S12
2017
3-1
178 3-
1
圖 3-3 2017 14–15 S12
179
180
S12 內
內
181
產
182
S12 23
娛
183 S12
179 WDEP Wants, Direction/Doing, Evaluation,
Planning/Action 177
15–16
180 NIDA ASI (Addiction Severity Index)
181 S12
182 3-1
183 177 5–6
184
S12 S12 說
185
2017
184 3-1
185 S04
S01 HIV
2018
186
內
S12
說
S12
說 2014
20 2018
186 3-1 S12
⋯
⋯ ⋯ ⋯ ⋯⋯
⋯ ⋯
⋯⋯ ⋯
⋯ ⋯
⋯ ⋯
no news is good news
⋯⋯
⋯ ⋯⋯
⋯
絕
contingently S12
NA
S12 S12
S01 S02 S03 S09 187 S12
2018
S12
S12 2017
187 /
S12
內
S12
188 S07
coupon
S07
188
說 脫 吿
189
189
115 117
HIV
190
HIV
191
190
191 /
192
193
192
193
——
說
說 說
casing
194 說 說
— 195
196 Michael Burawoy
extended case method Burawoy Clifford Geertz
thick description intepretive case method
Burawoy Thomas Kuhn
Imre Lakatos
194 Charles C. Ragin, ‘Casing’ and the Process of Social Inquiry, in WHAT IS A
CASE?EXPLORING THE FOUNDATION OF SOCIAL INQUIRY 217 (Charles C. Ragin and Howard S. Becker eds.), 1992.
195 —
1–18 2007
Paul Willis —
—
Peter Conrad 2015
1 [Conrad, Peter. 2007. The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders. Baltimore, MD: Johns Hopkins University Press.]
Annemarie Mol 2019
2 [Mol, Annemarie. 2008. The Logic of Care. 1st ed. New York, NY: Routledge.]
1
https://web.stanford.edu/~xgzhou/zhou_book2017.pdf 2020 6 23
2019 2
2008
11 89–110
2010 Peter Conrad xviii–lxxi
2006 —
95 145–204
2007
10 283–322
2017
307–345
2007 —
1–18 2010
17–67
2007 31 6
15–24
2007 4
65–108
2011
13 1-65
2014 17 2
193–212
1993
Clonidine —— 7 1
2015
21 15–76
2011
30 6 604–616
2011 —
29 2 111–180
2008
2017 1998–2017
2006
2003
2013
2001
2010 —
2007
2011
2015
2012
—
2003 —
2003
2017 —
2007
Campbell , Nancy D. 2017. Discovering Addiction: The Science and Politics of of Substance Abuse Research. 1st ed. Ann Arbor, MI: University of Michigan Press.
Conrad, Peter and Joseph W. Schneider eds. 1992. Deviance and Medicalization: From Badness to Sickness. Expanded ed. Philadelphia, PA: Temple University Press.
Deleuze, Gilles and Felix Guattari. 1987. A Thousand Plateaus: Capitalism and Schizophrenia.
2nd ed. Minneapolis, MN: University of Minnesota Press.
Pita, Diana Doyle. 2004. Addictions Counseling: A Practical and Comprehensive Guide for Counseling People with Addictions. Revised ed. Spring Valley, NY: Crossroad.
Mahoney, James and Kathleen Thelen. 2009. A Theory of Gradual Institutional Change.
Pp. 1–38 in Explaining Institutional Change: Ambiguity, Agency, and Power. Cambridge: Cambridge University Press.
Ragin, Charles. C. 1992. ‘Casing’ and the Process of Social Inquiry. Pp. 217–226 in What is a Case? Exploring the Foundation of Social Inquiry. Cambridge: Cambridge University Press.
Garland, David. 2014. What is a ‘‘History of the Present’’? On Foucault’s Genealogies and their Critical Preconditions, Punishment & Society 16:365–384.
Mahoney, James. 2000. Path Dependence in Historical Sociology. Theory and Society 29:507–548.
Sunstein, Cass R. 1996. On the Expressive Function of Law. University of Pennsylvania Law Review 114: 2021–2053.
1-1
1 2
10
02-3366- oooo
02-3366-oooo
1-2
1 2
10
02-3366- oooo
02-3366-oooo
1-3
1 2
02-3366- oooo
02-3366-oooo
2-1
2-2
3-1
S12 S12
1400-1515
and
——
2014 S12
NA/AA
2014 S12
2015 S12
•
•
•
2015
S12
2017
•
o
o
o
o —
—
o 2015–17
57% 28%
• 2017
•
• LINE
4-5 M/
KPI NIDA
KPI
•
•
•
•
KPI
9:1 S06
•
•
• S06
•
o
o ——
o 3rd session
K
o
o
MDMA
o or contingency management
ABC
§
§
/
o
• 1st–2nd session 7th–8th session
o
——
o
o
§ ——
o
•
o
o
title
o
•
•
2
•
• session 6–
8
•
•
•
•
•
